 | | DRUG: Nitroglycerin | |
| Entry |
|
|---|
| Name |
Nitroglycerin (JP18/USP);
Glyceryl trinitrate;
Minitran (TN);
Nitro-bid (TN);
Nitro-dur (TN);
Nitromist (TN);
Transderm-nitro (TN) |
|---|
| Product |
NITRO-DUR (Ingenus Pharmaceuticals), NITROGLYCERIN (HF Acquisition Co LLC), NITROGLYCERIN (HF Acquisition Co. LLC), NITROGLYCERIN IN DEXTROSE (Baxter Healthcare Company), NITROGLYCERIN IN DEXTROSE (HF Acquisition Co LLC), NITROGLYCERIN LINGUAL (HF Acquisition Co LLC), NITROLINGUAL (Allegis Pharmaceuticals), NITROSTAT (A-S Medication Solutions), NITROSTAT (Henry Schein), NITROSTAT (Parke-Davis Div of Pfizer), NITROSTAT (Proficient Rx LP), NITROSTAT (Viatris Specialty LLC), RECTIV (Allergan) |
|---|
| Generic |
NITRO-BID (Savage Laboratories a division of Fougera Pharmaceuticals), NITROGLYCERIN (A-S Medication Solutions), NITROGLYCERIN (A-S Medication Solutions), NITROGLYCERIN (A-S Medication Solutions), NITROGLYCERIN (Advagen Pharma), NITROGLYCERIN (Alvogen), NITROGLYCERIN (American Regent), NITROGLYCERIN (Aurobindo Pharma Limited), NITROGLYCERIN (Bryant Ranch Prepack), NITROGLYCERIN (Cosette Pharmaceuticals), NITROGLYCERIN (Dr. Reddys Laboratories), NITROGLYCERIN (Glenmark Pharmaceuticals), NITROGLYCERIN (Golden State Medical Supply), NITROGLYCERIN (Greenstone LLC), NITROGLYCERIN (HF Acquisition Co LLC), NITROGLYCERIN (HF Acquisition Co LLC), NITROGLYCERIN (HF Acquisition Co LLC), NITROGLYCERIN (HF Acquisition Co LLC), NITROGLYCERIN (Henry Schein), NITROGLYCERIN (Lifestar Pharma LLC), NITROGLYCERIN (Medical Purchasing Solutions), NITROGLYCERIN (Medical Purchasing Solutions), NITROGLYCERIN (Medical Purchasing Solutions), NITROGLYCERIN (Medical Purchasing Solutions), NITROGLYCERIN (Mylan Pharmaceuticals), NITROGLYCERIN (Natco Pharma USA LLC), NITROGLYCERIN (NuCare Pharmaceuticals), NITROGLYCERIN (NuCare Pharmaceuticals), NITROGLYCERIN (Proficient Rx LP), NITROGLYCERIN (Proficient Rx LP), NITROGLYCERIN (Proficient Rx LP), NITROGLYCERIN (REMEDYREPACK), NITROGLYCERIN (Zydus Lifesciences Limited), NITROGLYCERIN (Zydus Pharmaceuticals (USA)), NITROGLYCERIN LINGUAL (Allegis Pharmaceuticals), NITROGLYCERIN LINGUAL (HF Acquisition Co LLC), NITROGLYCERIN LINGUAL (HF Acquisition Co LLC), NITROGLYCERIN LINGUAL (Padagis Israel Pharmaceuticals), NITROGLYCERIN TRANSDERMAL INFUSION SYSTEM (Dr. Reddy's Laboratories) |
|---|
| Formula |
C3H5N3O9
|
|---|
| Exact mass |
227.0026
|
|---|
| Mol weight |
227.0865
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01657 Nitrovasodilator
DG03231 Antihypertensive
|
|---|
| Remark |
| Product (mixture): | D05352<JP> |
|
|---|
| Efficacy |
Antihypertensive, Vasodilator (coronary) |
|---|
| Disease |
Coronary artery disease [DS: H01742] Angina pectoris [DS: H01632] Acute myocardial infarction [DS: H01730] |
|---|
| Comment |
Name previously used: Glyceryl trinitrate
Organic nitrate
Nitric oxide donor
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01D VASODILATORS USED IN CARDIAC DISEASES
C01DA Organic nitrates
C01DA02 Glyceryl trinitrate
D00515 Nitroglycerin (JP18/USP) <JP/US>
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AE Muscle relaxants
C05AE01 Glyceryl trinitrate
D00515 Nitroglycerin (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Vasodilators
Vasodilators, Direct-acting Arterial/Venous
Nitroglycerin
D00515 Nitroglycerin (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D00515 Nitroglycerin (JP18/USP)
217 Vasodilators
2171 Coronary dilators
D00515 Nitroglycerin (JP18/USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01657 Nitrovasodilator
D00515 Nitroglycerin
DG03231 Antihypertensive
D00515 Nitroglycerin
Drug classes [BR:br08332]
Cardiovascular agent
DG03231 Antihypertensive
D00515 Nitroglycerin
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00515 Nitroglycerin tablets
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C1c C 25.0868 -17.7109
2 C1b C 25.0926 -16.3122
3 C1b C 25.0751 -19.1097
4 O2a O 23.6822 -17.7109
5 O2a O 26.4914 -16.3122
6 O2a O 26.4797 -19.1097
7 N2b N 22.2834 -17.7051 #+
8 N2b N 27.8900 -16.3122 #+
9 N2b N 27.8783 -19.1097 #+
10 O3a O 22.2776 -16.3063
11 O3a O 20.8848 -17.6992 #-
12 O3a O 27.8841 -14.9134
13 O3a O 29.2946 -16.3122 #-
14 O3a O 27.8724 -17.7109
15 O3a O 29.2770 -19.1097 #-
BOND 14
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 4 7 1
7 5 8 1
8 6 9 1
9 7 10 2
10 7 11 1
11 8 12 2
12 8 13 1
13 9 14 2
14 9 15 1
|
|---|
|
» Japanese version » Back
|
|